Use Device Component in Combo Product Trials, Produce Drug-Level Data
Drugmakers should include the device component of a combination product in the pivotal trial of the drug or biologic or face additional regulatory hurdles later, a top FDA official said.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.